PMA device
FARAPULSE Pulsed Field Ablation System (FARAWAVE Pulsed Field Ablation Catheter
Farapulse, Inc. · Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation (QZI, Class III) · First FDA decision Jan 30, 2024, newest Aug 25, 2026Atrial fibrillation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
7
PMA pathway
Device trials
579
Naming "Pulsed Field"
MAUDE reports
1,780
Brand "Pulsed Field", since 2015
PubMed studies
19,343
Mentioning "Pulsed Field"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing FARAPULSE Pulsed Field Ablation System (FARAWAVE Pulsed Field Ablation Catheter
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 7 decisions filed under this name.
- FARAPULSE Pulsed Field Ablation System (FARAWAVE Pulsed Field Ablation Catheter, FARASTAR Catheter Connection Cable,PMA supplement
P230030-S016 · Decided Aug 25, 2026 · 389 days after receipt · Normal 180 Day Track No User Fee
Device type: Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation (QZI) · Cardiology
- FARAPULSE Pulsed Field Ablation SystemPMA supplement
P230030-S018 · Decided Aug 6, 2026 · 176 days after receipt · Normal 180 Day Track No User Fee
Device type: Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation (QZI) · Cardiology
- FARAPULSE Pulsed Field Ablation SystemPMA supplement
P230030-S014 · Decided Aug 14, 2025 · 36 days after receipt · Normal 180 Day Track No User Fee
Device type: Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation (QZI) · Cardiology
3 more FDA decisions with a free account
Older decisions: P230030
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Percutaneous Left Atrial Appendage Closure (LAAC)National determinationOn the books20.34Updated Nov 4, 2026
- Percutaneous Left Atrial Appendage (LAA) Closure TherapyNational analysisReview closedCAG-00445NUpdated Sep 21, 2026
- Cardiac Catheterization Performed In Other Than A Hospital SettingNational analysisReview closedCAG-00166NUpdated Sep 16, 2026
- Cardiac Catheterization Performed in Other than a Hospital Setting - RETIREDNational determinationOn the books20.25Updated Dec 3, 2024
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33959CGS Administrators, LLCUpdated Oct 30, 2026
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33557Wellpoint FederalUpdated Jul 14, 2026
- Percutaneous minimally invasive fusion/stabilization of the sacroiliac joint for the treatment of back painLocal determinationIn effectL36000WPS Insurance CorporationUpdated May 21, 2026
- Irreversible Electroporation for CancerLocal determinationIn effectL40205Palmetto GBAUpdated May 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Pulsed Field", any status and sponsor, newest update first.
- Combined Pulsed-field Ablation (PFA) and Left Atrial Appendage Occlusion Using Watchman Flx or AmuletPivotal-lookingActive, not recruiting
Prince of Wales Hospital, Shatin, Hong KongAcademic, hospital or other
NCT05560204 · 200 participants (planned) · Start Jan 1, 2023 · Primary completion Dec 31, 2027
Device: Combined Pulsed-field Ablation (PFA) + Left Atrial Appendage Occlusion (LAAO) · For: Combined Pulsed-field Ablation (PFA)
Sites: Jordon, Hong Kong; Hong Kong, Hong Kong; Taipa, Macau
- Phase I Trial of High-Density Theta Burst Stimulation (hdTBS)Not yet recruiting
National Institute on Drug Abuse (NIDA)NIH
NCT06868914 · 40 participants (planned) · Start Nov 24, 2026 · Primary completion Jan 13, 2028
Device: TMS (MagVenture MagPro 100 with MagOption) · For: Healthy Volunteers
Sites: Hartford, Connecticut; Baltimore, Maryland
University of California, San FranciscoAcademic, hospital or other
NCT07487844 · 20 participants (planned) · Start Jun 29, 2026 · Primary completion Dec 31, 2028
Device: Pulsed Electric Field (PEF) System · For: Metastatic Breast Cancer; Breast Cancer
Sites: San Francisco, California
576 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Pulsed Field", and for the whole product code for context.
This brand
1,780 reports: 985 malfunction, 742 injury, 43 death
Whole product code QZI
10,522 reports: 5,457 malfunction, 4,777 injury, 245 death
Newest reports for this brand
2124215-2026-57840 · Received Oct 30, 2026 · Event dated Oct 15, 2026
Device type: Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation (QZI)
Device problem as coded: Off-Label Use
Patient problem as coded: Non specific EKG/ECG Changes; Hemorrhage/Blood Loss/Bleeding; Low Blood Pressure/ Hypotension; Pericardial Effusion
2124215-2026-57614 · Received Oct 29, 2026 · Event dated Jun 17, 2026
Device type: Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation (QZI)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Low Blood Pressure/ Hypotension
- FARAWAVE NAV Pulsed Field AblationMalfunction
2124215-2026-57251 · Received Oct 28, 2026 · Event dated Oct 20, 2026
Device type: Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation (QZI)
Device problem as coded: Contamination
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- FARASTAR Ablation Generator EU, Pulsed Field Ablation Generator, Product ID 61M401; Percutaneous Cardiac Ablation CatheterOpen, Classified
Z-2750-2026 · Started Jun 11, 2026 · Posted by FDA Jul 17, 2026
Reason given: Labeling discrepancy: Devices distributed with Instructions For Use (IFU) did not include FARAPOINT PFA catheter information.
Cause as FDA categorized it: Under Investigation by firm · Device type: Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation (QZI)
- FARASTAR Pulsed Field Ablation Generator, Product ID M004PFCE61M401; Percutaneous Cardiac Ablation CatheterOpen, Classified
Z-2751-2026 · Started Jun 11, 2026 · Posted by FDA Jul 17, 2026
Reason given: Labeling discrepancy: Devices distributed with Instructions For Use (IFU) did not include FARAPOINT PFA catheter information.
Cause as FDA categorized it: Under Investigation by firm · Device type: Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation (QZI)
- FARASTAR PFA Generator, Product ID M004PFCE61M460; Percutaneous Cardiac Ablation CatheterOpen, Classified
Z-2752-2026 · Started Jun 11, 2026 · Posted by FDA Jul 17, 2026
Reason given: Labeling discrepancy: Devices distributed with Instructions For Use (IFU) did not include FARAPOINT PFA catheter information.
Cause as FDA categorized it: Under Investigation by firm · Device type: Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation (QZI)
2 more recall records with a free account
Published research
The most relevant PubMed records for "Pulsed Field"[tiab]. The summary above synthesizes these.
- Pulsed Field Ablation.
Zou F, Di Biase L · Card Electrophysiol Clin · 2025Editorial
- Hemolysis after pulsed-field ablation of atrial fibrillation.
Xu Y, Gulburak TK, Lu Y, et al. · Heart Rhythm · 2025Review, Research Support, Non-U.S. Gov't
- Life-Threatening Delayed Myocardial Ischemia and Malignant Arrhythmias Occurring After Pulsed Field Ablation of Atrial Fibrillation.
Gunawardene MA, Schmidt B, Peichl P, et al. · Circulation · 2026Letter
- Pulsed field ablation for atrial fibrillation: Moving the field forward?
Mekary W, Merchant FM · J Cardiovasc Electrophysiol · 2023Editorial, Comment
- Pulsed-field gel electrophoresis.
Maule J · Mol Biotechnol · 1998Review
- Pulsed-field ablation: A little force to be reckoned with.
Savona SJ, Hummel J · J Cardiovasc Electrophysiol · 2023Editorial, Comment
- Pulsed-Field Ablation and the Coronary Arteries: Not So Simple.
Wilber DJ · JACC Clin Electrophysiol · 2022Editorial
- Radiofrequency and Pulsed Field Ablation: Keeping Your Options Open.
Haines DE · JACC Clin Electrophysiol · 2023Editorial, Research Support, Non-U.S. Gov't
- Ventricular tachycardia: Focal pulsed field electroporation as a rescue therapy.
Santos RR, Paiva MS, Amador R, et al. · Heart Rhythm O2 · 2024Editorial
- Effectiveness of AF pulsed field ablation with a variable-loop circular catheter: 12-month VARIPURE results.
Scherr D, Bessière F, Kronborg MB, et al. · Europace · 2026
- Ventricular Pulsed-Field Ablation: Pushing for More or Pushing too Far?
Koruth JS, Nies M · JACC Clin Electrophysiol · 2023Editorial, Comment
- Pulsed Field Ablation: A Comprehensive Update.
Ezzeddine FM, Asirvatham SJ, Nguyen DT · J Clin Med · 2024Review
Other devices of this type
Also filed under product code QZI.
- Volt PFA SystemAbbott Medical · PMA 2026
- VARIPULSE Catheter, TRUPULSE Generator with Connection Interface Unit (CIU)Biosense Webster, Inc. · PMA 2026
- Sphere-9 Catheter and Affera Ablation SystemMedtronic, Inc. · PMA 2026
- PulseSelect Pulsed Field Ablation (PFA) systemMedtronic, Inc. · PMA 2026
- Globe® Catheter and Globe® Pulsed Field SystemKardium, Inc. · PMA 2026
- PulseSelect Pulse Field Ablation (PFA) CatheterMedtronic, Inc. · PMA 2026
- FARASTAR Pulsed Field Ablation (PFA) GeneratorFarapulse, Inc. · PMA 2025
- Globe® Pulsed Field SystemKardium, Inc. · PMA 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.